General Information of the Compound
Compound ID |
CP0397545
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-(4-Methyl-piperazin-1-yl)-quinoline
Show/Hide
|
||||||||||||||||||
Synonyms |
0YV1ZIR6S0
1-(2-Quinolyl)-4-methylpiperazine
2-(4-Methyl-piperazin-1-yl)-quinoline
2-(4-Methylpiperazinyl)-quinoline
2-(4-methylpiperazin-1-yl)quinoline
AC1L1JF3
AKOS005453926
BDBM50053631
BPBio1_001081
Biomol-NT_000084
CCG-205080
CHEBI:64164
CHEMBL288591
CTK6I3065
DTXSID8043731
HOMWNUXPSJQSSU-UHFFFAOYSA-N
Lopac-Q-107
Lopac0_001000
MCULE-4786527390
MolPort-006-384-975
N-methylquipazine
Oprea1_654246
SCHEMBL606721
STK362919
Tocris-0566
UNII-0YV1ZIR6S0
ZINC403653
quinoline, 2-(4-methyl-1-piperazinyl)-
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C14H17N3
|
||||||||||||||||||
Molecular Weight |
227.311
|
||||||||||||||||||
Canonical SMILES |
CN1CCN(CC1)c1ccc2ccccc2n1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C14H17N3/c1-16-8-10-17(11-9-16)14-7-6-12-4-2-3-5-13(12)15-14/h2-7H,8-11H2,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
HOMWNUXPSJQSSU-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02227, 5-hydroxytryptamine receptor 3A
Protein ID: PT01711, Histamine H4 receptor
Clinical Information about the Compound